MALAT1 and diabetes mellitus: Hypoxia—which is a central pathophysiological phenomenon in diabetes-targeted organs—induces transactivation of the MALAT1 promoter through enhanced activity of the hypoxia-inducible factor-1α (HIF-1α) in vitro [116].